Citation tools
"Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer." Clinical Cancer Research
24.9
(2018):
2116-2127.
Web. 18 April. 2021.